IV and Infusion Therapies Available at Encompass Healthcare
The Encompass HealthCare infusion center is a convenient, comfortable and friendly place to receive your intravenous medications. It is staffed by caring doctors and technicians who treat you like family and are dedicated to providing you with the highest level of professional health care possible. We serve all cities in Oakland County, Wayne County, Livingston County, and Washtenaw County, including West Bloomfield, Bloomfield Hills, Birmingham, Troy, Farmington/Farmington Hills, Southfield/Berkley, Novi, Northville, Brighton, Commerce Township, Walled Lake, and the greater Metro Detroit area.
Some of the IV and Infusion medicines available at Encompass HealthCare include:
- Prolastin, Aralast
- Intavenous immunoglobulin
- Neupogen, Nuelasta
- Growth hormone
I.V. Antibiotics available include:
Approved uses: psoriasis, psoriatic arthritis, rheumatoid arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis
IV and Infusion therapies are based on weight and are administered every 4-8 weeks after induction. Intravenous infusion time is approximately three hours. Infusions can be scheduled seven days a week around the patient’s schedule.
Approved uses: rheumatoid arthritis
Infusion Therapy: 1000 mg per IV infusion separated by two weeks. This medication is currently given with methotrexate.
Approved uses: rheumatoid arthritis
Infusion therapies are based on patient body weight. IV infusions lasts only 30 minutes are is administered at two- and four weeks after the first infusion; and then every four weeks thereafter.
Approved uses: osteoporosis in post-menopausal women
Infusion Therapy: 3mg per IV injection over 15-30 seconds every 3 months. This drug must be administered by a health professional.
Approved uses: hypercalcemia of malignancy, multiple myeloma and bone metastases of solid tumors.
Infusion therapy: 4mg in 100cc sterile .9 sodium chloride over no less than 15minutes. Treatment frequency is based on diagnosis. This drug is best administered by a health professional.
Approved uses: multiple sclerosis-relapsing forms. Prescribed to delay the progression of physical disability and to reduce the frequency of clinical relapse.
Infusion therapy: 300mg in 100cc .9NaCl over one hour every four weeks.
PROLASTIN or ARALAST
Approved uses: emphysema due to congenital alpha1-antitrypsin deficiency. This disease usually presents in the third and fourth decades of life.
Infusion therapy: 60 mg/kg of body weight in sterile water over 30 minutes weekly. Treatment is indefinite. Product must be properly stored and maintained to prevent diminished activity. Admixing must be done according to strict guidelines by professionals with available sterile hoods like those at Encompass HealthCare.
Approved uses: immunodeficiency, immune thrombocytopenic purport (ITP) and chronic demyelinating peripheral neuropathy.
Infusion therapy is based on weight and diagnosis. Typically, infusions last for two to four hours, once per month.
Approved uses: anemia (abnormally low hemoglobin) resulting from chemotherapy, chronic renal insufficiency, or HIV.
Infusion therapy: subcutaneous or short IV infusion, 15-30 minutes, given weekly or once every three weeks until target hemoglobin is achieved. Shorter-acting Epogen is available for more frequent and more acute indications. Dose varies based on patient weight and specific indication listed in the approved uses above. Should be administered under the supervision of a healthcare professional such as at Encompass HealthCare.
Approved uses: to decrease the incidence of infection due to significantly depleted WBC (white blood cell) counts in patients undergoing chemotherapy. Shorter acting Neupogen is also available for transiently low WBC counts due to chemotherapy.
Infusion therapy: subcutaneous or short IV infusion, 15-30 minutes, administered once per chemotherapy cycle. Neupogen is used for more frequent administration in temporary conditions and dose is based on patient weight with daily injections/infusions until target WBC count is achieved.
Approved uses: adult growth hormone deficiency, malnutrition from AIDS, idiopathic short stature
Infusion therapy: subcutaneous injection. Self-administration is optimal.
Approved uses: multiple chronic inflammatory disorders which have acute breakthroughs or temporary relapses. Examples include rheumatoid arthritis, Lupus and multiple sclerosis. Additionally, the drug is used for asthma, sinusitis and allergic reactions.
Approved uses: acute pain syndromes, migraine
Infusion: short IV infusion over 30-60 seconds.
If you like this page, please share it!